Executive Search Success Story: Building Leadership for a PE-Backed Orthopedic Device Company Scaling Through M&A

How JRG Partners executed a highly confidential, multi-role North American executive search strategy that equipped a private equity-backed orthopedic device company with the specialized operations, product, and commercial leadership required to accelerate post-merger integration, streamline supply chains, and drive high-growth value creation following a series of strategic acquisitions.

The Challenge

A private equity-backed orthopedic device company specializing in sports medicine and surgical technologies was preparing for aggressive market expansion following a series of strategic acquisitions. While these M&A activities opened up significant commercial possibilities, they also introduced deep operational, structural, and cultural complexities that threatened execution timelines and investor returns:

• The immediate, high-stakes integration of newly acquired business units
• Inconsistent and fragmented commercial performance across different geographic regions
• Critical leadership gaps within core operations and product management functions
• Intensifying market competition from larger, well-capitalized legacy orthopedic manufacturers
• Escalating supply-chain and logistical complexity resulting directly from acquisition activity
• Succession concerns and key-person vulnerabilities among senior leadership
• An absolute need for agile executives experienced in fast-paced, high-growth medical technology environments

The Board of Directors and executive leadership team determined that a synchronized, strategic hiring initiative would be essential to align operations and achieve their aggressive growth objectives. The confidential mandate covered a Chief Operating Officer, VP Product Management, VP Operations, VP Supply Chain, Director of Commercial Excellence, and Regional Business Leaders. The company required an executive search partner with an intimate understanding of private equity milestones, operational scale-ups, and the medical device lifecycle.

Why They Chose JRG Partners

Deep Orthopedic Device Industry Expertise

JRG Partners maintains dedicated recruiting practices focused explicitly on orthopedic devices, sports medicine, surgical technologies, healthcare innovation, and life sciences leadership. Our consultants possess an intimate operational understanding of how to scale orthopedic organizations while maintaining strict operational excellence and regulatory compliance standards.

Access to Passive Orthopedic Leaders

The high-performing executives required to turn complex acquisitions into value-generating engines are rarely looking for work on public job boards. JRG Partners bypassed traditional resume channels, leveraging extensive personal industry relationships and targeted market intelligence to identify and attract proven leaders from top-performing orthopedic and medical technology companies.

Confidential Search Execution

Because multiple positions involved sensitive corporate restructuring and succession planning, discretion was paramount. JRG Partners conducted highly confidential searches that successfully insulated active production pipelines, maintained organizational stability, and protected employee morale during a major transitional phase.

True Nationwide Reach

Sourcing elite operational and commercial leaders required an unconstrained approach across North America’s primary medical technology clusters. JRG Partners systematically mapped the entire geographic landscape to uncover specialized orthopedic leaders capable of supporting long-term, cross-border corporate growth.

Our Executive Search Strategy

Phase 1 — Leadership & M&A Integration Assessment

Our consultants partnered directly with the CEO, Board members, and HR leadership to thoroughly assess corporate growth objectives, clear post-merger integration priorities, diagnose capability gaps, analyze product-development goals, and map cultural-alignment criteria. Rather than matching candidates to generic job templates, we co-authored leadership profiles built for immediate PE-backed scale.

Phase 2 — Comprehensive Sector Mapping

JRG Partners executed an intensive market-mapping initiative covering orthopedic device manufacturers, sports medicine companies, surgical technology organizations, healthcare innovation firms, medical technology startups, global device manufacturers, and private equity-backed healthcare businesses. More than 500 executive profiles were identified and systematically evaluated across North America.

Phase 3 — Targeted Executive Engagement

Using a research-driven, discreet outreach framework, our consultants directly engaged leaders with a demonstrated history of success in corporate integration, commercial leadership, product-lifecycle management, operational excellence, supply-chain optimization, and revenue acceleration. Only candidates proving measurable business impact and leadership excellence advanced through initial screening.

Phase 4 — Multi-Dimensional Vetting & Selection

Each finalist underwent a comprehensive evaluation covering strategic leadership capability, medical device domain expertise, operational leadership under private equity expectations, team-building effectiveness, change-leadership success, financial acumen, cultural alignment, and long-term retention potential.

Key Outcomes

• 500+ targeted orthopedic, sports medicine, and surgical technology executive profiles mapped across primary North American medical device and engineering corridors.
• Successfully built and integrated a complete, six-member executive core spanning global operations, product portfolio management, and commercial excellence within 10 months.
• Accelerated post-merger integration timelines and synchronized corporate alignment across previously isolated, newly acquired business units.
• Optimized multi-facility supply chains and eliminated operational redundancies under incoming operations leadership, expanding operating margins.
• Streamlined product-development pipelines and expanded the sports medicine product portfolio by installing elite product-lifecycle executives.
• Protected corporate data, market share, and employee morale during sensitive organizational restructuring through strict search confidentiality.
• Provided the private equity sponsor and Board of Directors with a highly scalable management infrastructure primed to drive rapid enterprise value creation.